[1]
|
Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. https://doi.org/10.1001/jama.2016.0287
|
[2]
|
Chung, H., Wickel, J., Brunkhorst, F.M. and Geis, C. (2020) Sepsis-Associated Encephalopathy: From Delirium to Dementia? Journal of Clinical Medicine, 9, Article 703. https://doi.org/10.3390/jcm9030703
|
[3]
|
Huang, Y., Chen, R., Jiang, L., Li, S. and Xue, Y. (2021) Basic Research and Clinical Progress of Sepsis-Associated Encephalopathy. Journal of Intensive Medicine, 1, 90-95. https://doi.org/10.1016/j.jointm.2021.08.002
|
[4]
|
Haileselassie, B., Joshi, A.U., Minhas, P.S., Mukherjee, R., Andreasson, K.I. and Mochly-Rosen, D. (2020) Mitochondrial Dysfunction Mediated through Dynamin-Related Protein 1 (Drp1) Propagates Impairment in Blood Brain Barrier in Septic Encephalopathy. Journal of Neuroinflammation, 17, Article No. 36. https://doi.org/10.1186/s12974-019-1689-8
|
[5]
|
Yu, Y., Feng, J., Lian, N., Yang, M., Xie, K., Wang, G., et al. (2020) Hydrogen Gas Alleviates Blood-Brain Barrier Impairment and Cognitive Dysfunction of Septic Mice in an Nrf2-Dependent Pathway. International Immunopharmacology, 85, Article ID: 106585. https://doi.org/10.1016/j.intimp.2020.106585
|
[6]
|
Akrout, N., Sharshar, T. and Annane, D. (2009) Mechanisms of Brain Signaling during Sepsis. Current Neuropharmacology, 7, 296-301. https://doi.org/10.2174/157015909790031175
|
[7]
|
Catalão, C.H.R., Santos-Júnior, N.N., da Costa, L.H.A., Souza, A.O., Alberici, L.C. and Rocha, M.J.A. (2016) Brain Oxidative Stress during Experimental Sepsis Is Attenuated by Simvastatin Administration. Molecular Neurobiology, 54, 7008-7018. https://doi.org/10.1007/s12035-016-0218-3
|
[8]
|
Alexander, J.J., Jacob, A., Cunningham, P., Hensley, L. and Quigg, R.J. (2008) TNF Is a Key Mediator of Septic Encephalopathy Acting through Its Receptor, TNF Receptor-1. Neurochemistry International, 52, 447-456. https://doi.org/10.1016/j.neuint.2007.08.006
|
[9]
|
Pierrakos, C., Attou, R., Decorte, L., Kolyviras, A., Malinverni, S., Gottignies, P., et al. (2014) Transcranial Doppler to Assess Sepsis-Associated Encephalopathy in Critically Ill Patients. BMC Anesthesiology, 14, Article No. 45. https://doi.org/10.1186/1471-2253-14-45
|
[10]
|
Della Giovampaola, M., Cavalli, I. and Mascia, L. (2022) Neuropsychological Outcome of Critically Ill Patients with Severe Infection. Biomedicines, 10, Article 526. https://doi.org/10.3390/biomedicines10030526
|
[11]
|
Caldas, J., Quispe-Cornejo, A.A., Crippa, I.A., Subira, C., Creteur, J., Panerai, R., et al. (2022) Cerebral Autoregulation Indices Are Not Interchangeable in Patients with Sepsis. Frontiers in Neurology, 13, Article 760293. https://doi.org/10.3389/fneur.2022.760293
|
[12]
|
Cenini, G., Lloret, A. and Cascella, R. (2019) Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 2105607. https://doi.org/10.1155/2019/2105607
|
[13]
|
Dumbuya, J.S., Li, S., Liang, L. and Zeng, Q. (2023) Paediatric Sepsis-Associated Encephalopathy (SAE): A Comprehensive Review. Molecular Medicine, 29, Article No. 27. https://doi.org/10.1186/s10020-023-00621-w
|
[14]
|
Oliveira-Pelegrin, G.R., Basso, P.J. and Rocha, M.J.A. (2014) Cellular Bioenergetics Changes in Magnocellular Neurons May Affect Copeptin Expression in the Late Phase of Sepsis. Journal of Neuroimmunology, 267, 28-34. https://doi.org/10.1016/j.jneuroim.2013.12.006
|
[15]
|
Fu, Q., Wu, J., Zhou, X., Ji, M., Mao, Q., Li, Q., et al. (2018) NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy. Inflammation, 42, 306-318. https://doi.org/10.1007/s10753-018-0894-4
|
[16]
|
Wang, Y., Liu, X., Wang, Q. and Yang, X. (2020) Roles of the Pyroptosis Signaling Pathway in a Sepsis-Associated Encephalopathy Cell Model. Journal of International Medical Research, 48. https://doi.org/10.1177/0300060520949767
|
[17]
|
唐振东, 李探, 曾浩, 等. 中医药治疗脓毒症相关性脑病研究进展[J]. 中国中医急症, 2024, 33(11): 2064-2068.
|
[18]
|
谭文章, 邓竣, 伍大华, 等. 脓毒症相关性脑病的中医药治疗作用机制研究进展[J]. 湖南中医杂志, 2023, 39(8): 197-200.
|
[19]
|
Zhang, D., Micek, S.T. and Kollef, M.H. (2015) Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients with Sepsis. Critical Care Medicine, 43, 2133-2140. https://doi.org/10.1097/ccm.0000000000001140
|
[20]
|
雷紫涵, 吴晓静. 脓毒症相关性脑病的研究进展[J/OL]. 武汉大学学报(医学版), 1-6. https://doi.org/10.14188/j.1671-8852.2024.0549, 2025-03-05.
|
[21]
|
Gofton, T.E. and Young, G.B. (2012) Sepsis-associated Encephalopathy. Nature Reviews Neurology, 8, 557-566. https://doi.org/10.1038/nrneurol.2012.183
|
[22]
|
Pandharipande, P.P., Sanders, R.D., Girard, T.D., McGrane, S., Thompson, J.L., Shintani, A.K., et al. (2010) Effect of Dexmedetomidine versus Lorazepam on Outcome in Patients with Sepsis: An a Priori-Designed Analysis of the MENDS Randomized Controlled Trial. Critical Care, 14, Article No. R38. https://doi.org/10.1186/cc8916
|
[23]
|
Xu, X., Liu, L., Wang, Y., Wang, C., Zheng, Q., Liu, Q., et al. (2019) Caspase-1 Inhibitor Exerts Brain-Protective Effects against Sepsis-Associated Encephalopathy and Cognitive Impairments in a Mouse Model of Sepsis. Brain, Behavior, and Immunity, 80, 859-870. https://doi.org/10.1016/j.bbi.2019.05.038
|
[24]
|
单贝贝, 谢颖桢, 牛丽强, 等. 基于“卫气营血”理论辨治脓毒症相关性脑病经验[J]. 北京中医药, 2024, 43(6): 707-709.
|
[25]
|
黄坡, 赵京霞, 苏芮, 等. 刘清泉教授对脓毒症相关性脑病的认识及其中医研究思路探讨[J]. 世界中医药, 2018, 13(10): 2390-2392, 2395.
|
[26]
|
戴春钦, 林巧燕. 牛黄承气汤治疗脓毒症脑病临床疗效的观察[J]. 中医临床研究, 2020, 12(27): 98-100.
|
[27]
|
郑福奎, 唐农, 吴林, 等. 清瘟败毒饮对脓毒症相关性脑病大鼠脑组织与TLR4介导的炎性因子的影响[J]. 广西中医药, 2017, 40(2): 70-73.
|
[28]
|
梁道业, 林正佳, 黄捷敏, 等. 涤痰醒脑承气汤干预对脓毒症脑病患者脑损伤标志物的影响[J]. 中国社区医师, 2018, 34(29): 118-119.
|
[29]
|
张云海, 邓梦华, 马明远. 通窍活血方治疗血瘀型脓毒性脑病患者的临床疗效观察[J]. 中医临床研究, 2021, 13(7): 63-66.
|
[30]
|
钱风华, 朱亮, 顼志兵, 等. 升降散治疗脓毒症性脑病临床疗效观察[J]. 上海中医药杂志, 2010, 44(6): 48-50.
|
[31]
|
王琳, 吴建鹏, 余旭超, 等. 安宫牛黄丸治疗脓毒症相关性脑病患者的临床观察[J]. 中国中医急症, 2022, 31(8): 1246-1249.
|
[32]
|
赵利, 张伟, 王小红. 醒脑静注射液治疗脓毒症相关性脑病的效果评价[J]. 当代医药论丛, 2020, 18(1): 153-154.
|
[33]
|
冯铠滨, 邓海霞, 吴鑫宇, 等. 参附注射液调节急危重症患者免疫功能的研究进展[J]. 辽宁中医药大学学报, 2024, 26(10): 189-195.
|
[34]
|
袁翔, 李建国, 黄越, 等. 电针足三里激活胆碱能抗炎通路抗大鼠感染性休克[J]. 武汉大学学报(医学版), 2007(2): 203-206.
|
[35]
|
林武, 杨芳, 张扬, 等. 通督调神针法对脓毒症相关性脑病患者认知功能的影响[J]. 针刺研究, 2019, 44(12): 888-892.
|
[36]
|
张云海, 谢维, 柳松涛, 等. 醒脑开窍针刺法治疗脓毒症相关性脑病临床研究[J]. 新中医, 2024, 56(20): 116-120.
|
[37]
|
谷婷, 王鑫, 杨欢, 等. 电针对颅脑损伤大鼠神经功能及凋亡相关蛋白Cyt-C、Caspase-9表达的影响[J]. 中国针灸, 2020, 40(7): 749-755.
|